PUBLICATION

Generation of mmp15b Zebrafish Mutant to Investigate Liver Diseases

Authors
Kim, O.H., An, H.S., Choi, T.Y.
ID
ZDB-PUB-200130-6
Date
2019
Source
Development & reproduction   23: 385-390 (Journal)
Registered Authors
Choi, Tae-Young
Keywords
CRISPR/Cas9, Fibrosis, Liver diseases, Regeneration, Zebrafish, mmp15b
MeSH Terms
none
PubMed
31993544 Full text @ Dev Reprod
Abstract
Upon gene inactivation in animal models, the zebrafish (Danio rerio) has become a useful model organism for many reasons, including the fact that it is amenable to various forms of genetic manipulation. Genome editing is a type of genetic engineering in which DNA is inserted, deleted, modified, or replaced in the genome of a living organism. Mainly, CRISPR (clustered regularly interspaced short palindromic repeats) Cas9 (CRISPR-associated protein 9) is a technology that enables geneticists to edit parts of the genome. In this study, we utilized this technology to generate an mmp15b mutant by using zebrafish as an animal model. MMP15 is the membrane-type MMP (MT-MMP) which is a recently identified matrix metalloproteinase (MMP) capable of degrading all kinds of extracellular matrix proteins as well as numerous bioactive molecules. Although the newly-established mmp15b zebrafish mutant didn't exhibit morphological phenotypes in the developing embryos, it might be further utilized to understand the role of MMP15 in liver-related diseases, such as liver fibrosis, and associated pathogeneses in humans.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping